PerkinElmer to sell off non-life sciences businesses, adopt new name

The life sciences giant plans to unload several businesses to New Mountain Capital for $2.45 billion in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.